Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Mediwound Ltd Ord Sh (MDWD)

Mediwound Ltd Ord Sh (MDWD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 67,620
  • Shares Outstanding, K 40,735
  • Annual Sales, $ 23,760 K
  • Annual Income, $ -13,550 K
  • 60-Month Beta 1.04
  • Price/Sales 2.83
  • Price/Cash Flow N/A
  • Price/Book 40.59
Trade MDWD with:

Options Overview Details

View History
  • Implied Volatility 212.08% ( -72.03%)
  • Historical Volatility 77.77%
  • IV Percentile 85%
  • IV Rank 31.63%
  • IV High 627.79% on 11/16/22
  • IV Low 19.74% on 03/14/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 280
  • Volume Avg (30-Day) 39
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 777

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.10
  • Number of Estimates 5
  • High Estimate -0.09
  • Low Estimate -0.11
  • Prior Year -0.15
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2400 +33.87%
on 10/27/22
1.6900 -1.78%
on 11/25/22
+0.3700 (+28.68%)
since 10/25/22
3-Month
1.2400 +33.87%
on 10/27/22
2.1800 -23.85%
on 08/30/22
-0.4300 (-20.57%)
since 08/25/22
52-Week
1.2100 +37.19%
on 06/17/22
3.3800 -50.89%
on 01/07/22
-1.0900 (-39.64%)
since 11/24/21

Most Recent Stories

More News
MediWound (MDWD) Reports Q3 Loss, Tops Revenue Estimates

MediWound (MDWD) delivered earnings and revenue surprises of -30% and 24.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

MDWD : 1.6600 (+0.61%)
CSBR : 6.80 (-4.30%)
CASI Pharmaceuticals, Inc. (CASI) Reports Q3 Loss, Lags Revenue Estimates

CASI Pharmaceuticals, Inc. (CASI) delivered earnings and revenue surprises of 25.49% and 1.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

CASI : 1.9700 (+1.03%)
MDWD : 1.6600 (+0.61%)
VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Tops Revenue Estimates

VYNE Therapeutics Inc. (VYNE) delivered earnings and revenue surprises of 0% and 67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

VYNE : 0.2291 (-0.17%)
MDWD : 1.6600 (+0.61%)
MediWound (MDWD) Reports Q2 Loss, Misses Revenue Estimates

MediWound (MDWD) delivered earnings and revenue surprises of -30% and 11.42%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

MDWD : 1.6600 (+0.61%)
LJPC : 6.22 (unch)
MediWound Reports Second Quarter 2022 Financial Results and Provides Company Updates

Positive Results in Two Phase 2 Trials of EscharEx FDA Assigned PDUFA Target Date of January 1, 2023 for NexoBrid BLA Enhanced the Board and Leadership...

MDWD : 1.6600 (+0.61%)
FibroGen (FGEN) Reports Q2 Loss, Misses Revenue Estimates

FibroGen (FGEN) delivered earnings and revenue surprises of 17.02% and 18.57%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

FGEN : 13.85 (-0.93%)
MDWD : 1.6600 (+0.61%)
MediWound Enhances Its Board and Executive Leadership Team

Mr. Nachum Shamir appointed as Chairman of the Board Dr. Robert Snyder appointed as Chief Medical Officer YAVNE, Israel, Aug. 08, 2022 (GLOBE NEWSWIRE)...

MDWD : 1.6600 (+0.61%)
MediWound Announces U.S. FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns

Prescription Drug User Fee Act (PDUFA) target date of January 1, 2023...

MDWD : 1.6600 (+0.61%)
MediWound (MDWD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

MediWound (MDWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MDWD : 1.6600 (+0.61%)
ENTA : 41.58 (-7.60%)
MediWound Schedules Second Quarter 2022 Financial Results

Conference Call and Webcast Scheduled for Tuesday, August 9, 2022 at 8:30 AM ET...

MDWD : 1.6600 (+0.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

MediWound Ltd. is a biotechnology niche specialty company. It is focused on developing, manufacturing and commercializing products that address unmet needs in the fields of severe burn and chronic wound management. The company is also developing NexoBrid for the removal of eschar, a dead or damaged tissue...

See More

Key Turning Points

3rd Resistance Point 1.7633
2nd Resistance Point 1.7267
1st Resistance Point 1.6933
Last Price 1.6600
1st Support Level 1.6233
2nd Support Level 1.5867
3rd Support Level 1.5533

See More

52-Week High 3.3800
Fibonacci 61.8% 2.5511
Fibonacci 50% 2.2950
Fibonacci 38.2% 2.0389
Last Price 1.6600
52-Week Low 1.2100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar